Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 8,000 shares at $104.75 ($839K) on 2021-10-07, disclosed to the SEC on 2021-10-12.
Open-market sale of $838k NBIX by Chief Research Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.75 | 3,000 | $314K | 37.5% |
| 2 | $104.85 | 5,000 | $524K | 62.5% |
| Total | $104.81 avg | 8,000 | $839K | 100% |
| Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |
| NBIX | SELL | 2020-05-11 | $1.8M | — | Filing → |